Global (United States, European Union and China) Vaccine Conjugate Market Research Report 2019-2025

Table of Contents

1 Vaccine Conjugate Market Overview

• 1.1 Product Overview and Scope of Vaccine Conjugate
• 1.2 Vaccine Conjugate Segment by Type
  • 1.2.1 Global Vaccine Conjugate Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Monovalent
  • 1.2.3 Multivalent
  • 1.2.4 Others
• 1.3 Vaccine Conjugate Segment by Application
  • 1.3.1 Vaccine Conjugate Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Influenza
  • 1.3.3 Meningococcal
  • 1.3.4 Pneumococcal
  • 1.3.5 Others
• 1.4 Global Vaccine Conjugate Market Size Estimates and Forecasts
  • 1.4.1 Global Vaccine Conjugate Revenue 2015-2026
  • 1.4.2 Global Vaccine Conjugate Sales 2015-2026
  • 1.4.3 Vaccine Conjugate Market Size by Region: 2020 Versus 2026

2 Global Vaccine Conjugate Market Competition by Manufacturers

• 2.1 Global Vaccine Conjugate Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Vaccine Conjugate Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Vaccine Conjugate Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Vaccine Conjugate Manufacturing Sites, Area Served, Product Type
• 2.5 Vaccine Conjugate Market Competitive Situation and Trends
  • 2.5.1 Vaccine Conjugate Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Vaccine Conjugate Players (Opinion Leaders)

3 Vaccine Conjugate Retrospective Market Scenario by Region

• 3.1 Global Vaccine Conjugate Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Vaccine Conjugate Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Vaccine Conjugate Market Facts & Figures by Country
  • 3.3.1 North America Vaccine Conjugate Sales by Country
  • 3.3.2 North America Vaccine Conjugate Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Vaccine Conjugate Market Facts & Figures by Country
  • 3.4.1 Europe Vaccine Conjugate Sales by Country
  • 3.4.2 Europe Vaccine Conjugate Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Vaccine Conjugate Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Vaccine Conjugate Sales by Region
  • 3.5.2 Asia Pacific Vaccine Conjugate Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Vaccine Conjugate Market Facts & Figures by Country
  • 3.6.1 Latin America Vaccine Conjugate Sales by Country
  • 3.6.2 Latin America Vaccine Conjugate Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Vaccine Conjugate Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Vaccine Conjugate Sales by Country
  • 3.7.2 Middle East and Africa Vaccine Conjugate Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Vaccine Conjugate Historic Market Analysis by Type

• 4.1 Global Vaccine Conjugate Sales Market Share by Type (2015-2020)
• 4.2 Global Vaccine Conjugate Revenue Market Share by Type (2015-2020)
• 4.3 Global Vaccine Conjugate Price Market Share by Type (2015-2020)
• 4.4 Global Vaccine Conjugate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Vaccine Conjugate Historic Market Analysis by Application

• 5.1 Global Vaccine Conjugate Sales Market Share by Application (2015-2020)
• 5.2 Global Vaccine Conjugate Revenue Market Share by Application (2015-2020)
• 5.3 Global Vaccine Conjugate Price by Application (2015-2020)

6 Company Profiles and Key Figures in Vaccine Conjugate Business

• 6.1 Merck & Co.
  • 6.1.1 Corporation Information
  • 6.1.2 Merck & Co. Description, Business Overview and Total Revenue
  • 6.1.3 Merck & Co. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Merck & Co. Products Offered
  • 6.1.5 Merck & Co. Recent Development
• 6.2 GlaxoSmithKline plc.
  • 6.2.1 GlaxoSmithKline plc. Vaccine Conjugate Production Sites and Area Served
  • 6.2.2 GlaxoSmithKline plc. Description, Business Overview and Total Revenue
  • 6.2.3 GlaxoSmithKline plc. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 GlaxoSmithKline plc. Products Offered
  • 6.2.5 GlaxoSmithKline plc. Recent Development
• 6.3 SutroVax
  • 6.3.1 SutroVax Vaccine Conjugate Production Sites and Area Served
  • 6.3.2 SutroVax Description, Business Overview and Total Revenue
  • 6.3.3 SutroVax Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 SutroVax Products Offered
  • 6.3.5 SutroVax Recent Development
• 6.4 Fablife.
  • 6.4.1 Fablife. Vaccine Conjugate Production Sites and Area Served
  • 6.4.2 Fablife. Description, Business Overview and Total Revenue
  • 6.4.3 Fablife. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Fablife. Products Offered
  • 6.4.5 Fablife. Recent Development
• 6.5 Pfizer
  • 6.5.1 Pfizer Vaccine Conjugate Production Sites and Area Served
  • 6.5.2 Pfizer Description, Business Overview and Total Revenue
  • 6.5.3 Pfizer Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Pfizer Products Offered
  • 6.5.5 Pfizer Recent Development
• 6.6 Sinovac Biotech Ltd.
  • 6.6.1 Sinovac Biotech Ltd. Vaccine Conjugate Production Sites and Area Served
  • 6.6.2 Sinovac Biotech Ltd. Description, Business Overview and Total Revenue
  • 6.6.3 Sinovac Biotech Ltd. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Sinovac Biotech Ltd. Products Offered
  • 6.6.5 Sinovac Biotech Ltd. Recent Development
• 6.7 Sanofi Pasteur SA.
  • 6.6.1 Sanofi Pasteur SA. Vaccine Conjugate Production Sites and Area Served
  • 6.6.2 Sanofi Pasteur SA. Description, Business Overview and Total Revenue
  • 6.6.3 Sanofi Pasteur SA. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Sanofi Pasteur SA. Products Offered
  • 6.7.5 Sanofi Pasteur SA. Recent Development

7 Vaccine Conjugate Manufacturing Cost Analysis

• 7.1 Vaccine Conjugate Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Vaccine Conjugate
• 7.4 Vaccine Conjugate Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Vaccine Conjugate Distributors List
• 8.3 Vaccine Conjugate Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Vaccine Conjugate Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Vaccine Conjugate by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Vaccine Conjugate by Type (2021-2026)
• 10.2 Vaccine Conjugate Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Vaccine Conjugate by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Vaccine Conjugate by Application (2021-2026)
• 10.3 Vaccine Conjugate Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Vaccine Conjugate by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Vaccine Conjugate by Region (2021-2026)
• 10.4 North America Vaccine Conjugate Estimates and Projections (2021-2026)
• 10.5 Europe Vaccine Conjugate Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Vaccine Conjugate Estimates and Projections (2021-2026)
• 10.7 Latin America Vaccine Conjugate Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Vaccine Conjugate Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List